Evidence map›Paper›PMID 24088955›Full record

ArticleKidney international2014

Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network.

Alicia T Morrish, Carmel M Hawley, David W Johnson, Sunil V Badve, Vlado Perkovic, Donna M Reidlinger, Alan Cass

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Continuous Quality Improvement Initiatives to Sustainably Reduce Peritoneal Dialysis-Related Infections in Australia and New Zealand.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis · 2016
    Review
  9. Review
  10. Optimizing Enrollment of Patients into Nephrology Research Studies.Clinical journal of the American Society of Nephrology : CJASN · 2016
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alicia T MorrishAustralasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
Carmel M Hawley1] Australasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, Queensland, Australia [2] Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
David W Johnson1] Australasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, Queensland, Australia [2] Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Sunil V Badve1] Australasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, Queensland, Australia [2] Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Vlado Perkovic1] Australasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, Queensland, Australia [2] The George Institute for Global Health, Sydney, New South Wales, Australia.
Donna M ReidlingerAustralasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
Alan Cass1] Australasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, Queensland, Australia [2] Menzies School of Health Research, Darwin, Northern Territory, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease is a major public health problem globally. Despite this, there are fewer high-quality, high-impact clinical trials in nephrology than other internal medicine specialties, which has led to large gaps in evidence. To address this deficiency, the Australasian Kidney Trials Network, a Collaborative Research Group, was formed in 2005. Since then, the Network has provided infrastructure and expertise to conduct patient-focused high-quality, investigator-initiated clinical trials in nephrology. The Network has not only been successful in engaging the nephrology community in Australia and New Zealand but also in forming collaborations with leading researchers from other countries. This article describes the establishment, development, and functions of the Network. The article also discusses the current and future funding strategies to ensure uninterrupted conduct of much needed clinical trials in nephrology to improve the outcomes of patients affected by kidney diseases with cost-effective interventions.

Indexed as

AustralasiaHumansNephrologyRandomized Controlled Trials as Topic

Identifiers

PMID24088955
PMCPMC3898483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.